Francis Baumgartner
5PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 18, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg
|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg
|Feb 20, 2024
Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity.Francis Baumgartner, Stefanos A Bamopoulos, Laura Faletti
|Dec 08, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.Francis Baumgartner, Constance Baer, Stefanos Bamopoulos
|Aug 02, 2022
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.Guus J J E Heynen, Francis Baumgartner, Michael Heider
Pageof 1
Frequent Collaborators
5 joint publications
Ulrich Keller
3 joint publications
Jan Braune
3 joint publications
Stefanos Bamopoulos
3 joint publications
Jan Krönke
3 joint publications
Matthias Wirth
2 joint publications
Yan Zhao
2 joint publications
Frederik Herzberg
2 joint publications
Stefan Habringer
2 joint publications
Marieluise Kirchner
2 joint publications
Sven Liebig
